Our experience with ticagrelor in the patients of acute coronary syndrome  by Jagdale, G.S. et al.
III (NDDM) included 6 patients. Mean BMI of group I, II and III was
23.5±3.7, 24.1±2.9 and 28.8±7.2 kg/m2 respectively. The difference
between the groups was statistically significant indicating higher
values in group II and group III. Mean HDL-C level of group I, II and
III was 34±5.5, 33.3±7 and 29.5±6.7 mg/dl respectively. The values
were less in patients with IGT and NDDM. Mean LDL-C level of
group I, II and III was 85.4±33.5, 94.6±32 and 122.6±44.7 mg/dl
respectively. The values were higher in patients in group II and III.
Mean TG level of group I, II and III was 121.8±44.2, 155.8±90.7 and
183.5±83.6 mg/dl respectively. The values were higher in patients
with IGT and NDDM. Mean TC level of group I, II and III was
147.8±35.8, 163.1±32.5 and 181.6±58.6 mg/dl respectively. The
values were higher in group II and III.
Mean Fasting insulin levels of group I, II and III was 4.3±1.9,
10±4.3 and 27.1±13.4 mIU/ml respectively indicating increased in-
sulin resistance in group III. The values of HOMA-IR were
increased in group II and III. When values of QUICKI were taken
into consideration then IR was found to be maximal in group III
than others.
Conclusions: Our study demonstrated that among Asian Indian
patients subjected to OGTT before discharge following AMI,
abnormal glucose tolerance was present in a significant (32%)
number of subjects, after the exclusion of those with known
diabetes. The present study also reinforces the high insulin
resistance in Indian subjects as indicated by BMI, lipid profile and
high levels of insulin and HOMA-IR I patients with IGT and NDDM.
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Background: Ticagrelor is an oral, reversible, direct-acting inhib-
itor of the adenosine diphosphate receptor P2Y12 that has a more
rapid onset and more pronounced platelet inhibition than clopi-
dogrel. We studied the clinical effects off TICAGRELOR at our
hospital in comparison with CLOPIDOGREL.
Methods: In this single center, observational study, we compared
Ticagrelor (180-mg loading dose, 90 mg twice daily thereafter) and
Clopidogrel (300-to-600-mg loading dose, 75 mg daily thereafter)
for the prevention of cardiovascular events in 240 patients
admitted to the hospital with an acute coronary syndrome, with
or without ST-segment elevation.
Results: At the end of the study period, total number of patients
included in the study were 240 patients out of which 60 (25%) were
treated with Ticagrelor and 180 ( 75 %) were treated with Clopi-
dogrel. In patients treated with Ticagrelor, 1 (1.7 %) died of Sudden
Cardiac arrest (? Myocardial infarction), 4 (7%) had myocardial
infarction. No cases of stroke were reported in Ticagrelor group. 2
(3.4 %) patients had major bleeding episodes ( 1 patient had large
hematoma at puncture site requiring 4 units of blood transfusion
and 1 patient had Intra-Cerebral bleed. 4 (7 %) patients had com-
plained of new onset dyspnea, which was evaluated with PFT
which showed no significant abnormality, oxygen saturations
were found to be normal. Patients were reassured and the drug
was continued and eventually patients tolerated the drugs well.
In patients treated with clopidogrel, 4(2.2 %) patients died, 2
patients had Myocardial infarction, 1 had major intra-cranial
bleed, 1 patient had sudden cardiac death. 15 (8.3%) had
myocardial infarction. 2 (1.1 %) patients had stroke. 5 (2.7 %) pa-
tients had major bleeding episodes ( 4 patient had large hema-
toma at puncture site requiring multiple units of blood
transfusion and 1 patient had Intra-Cerebral bleed). 4 (2.2 %) pa-
tients had complained of new onset dyspnea, which was evalu-
ated with PFT which showed no significant abnormality, oxygen
saturations were found to be normal. Patients were reassured and
the drug was continued and eventually patients tolerated the
drugs well.
Conclusion: In patients who had an acute coronary syndrome
with or without ST-segment elevation, treatment with Ticagrelor,
as compared with Clopidogrel, significantly reduced the rate of
death from vascular causes, myocardial infarction, or stroke, with
increase in the rate of overall major bleeding. Themajor limitation
of the study was that it wasn’t a randomized controlled trial and
comparatively small number of patients were studied.
Prognostic implication of stress hyperglycemia in
MI comparitive study between Diabetics and non-
diabetics
Kavya
Osmania general hospital, India
Background: Rise in blood glucose levels secondary to neuroen-
docrine changes during critical illness.
Methods: 100 patients with Acute MI were included over a period
of 6 months, patients with first time detected MI, with diabetes
and non-diabetics excluding patients with contraindications to
thrombolytic therapy, who are given dextrose before admission
with Hemoglobinopathies on sympathomimetic or sympatholytic
drugs,other co-morbid illnesses.Thrombolytics given, Random
blood sugar levels are taken at the time of admission blood sugars
are taken on 1st,2nd day. HbA1c levels are taken ,Heart rate, killips
class determined, 2D Echo was done -2nd day,Serial ECG’s were
taken daily for 1 week,Oral glucose tolerance test was done at the
time of discharge.
Results: Based on the ADMISSION BLOOD GLUCOSE (ABG) patients
with normoglycemia (classI) with ABG < 140 were 20, no of Non
ediabetics with Stress Hyperglycemia (class II)ABG >140,HbA1c
<6.6 are 40, Diabetics with ABG >140,(classIII) HbA1c >6.6are 40.
Mean Blood Glucose in classI is :93.5, classII is :161.025,classIII is
262.125 ,incidence of class 1 is 40(66.6%).Mean Age in class1 is 48,
classII is 51,diabetics is 58. males are effected more(75%) , Mean
HbA1class 1 - 5.32 classII - 5.37 classIII- 6.77 ,commonest site of
infarction is anterior wall MI . class 1 and II have moderate to
severe LV dysfunction more in Class II. Mean Ejection Fraction in
class1- 60%,classII - 51%,diabeticse 53%, ST segment reduction
classI is (71.8%),classII(51.6%) ,classIII( 60.8 %) .Complications are
more in Class II 28(46.6%) and Class III 10(25%) .LVF in Class II e
12(30%) in Class III 6(15%).Recurrent angina in Class -II 3 (7.5%)
Mortality in Class I e 0, Class II- 8 (20%), Class III- 6(17.45%). Mean
Blood Glucose where Morality occurred ClassII- 169,diabetics e
281 .Mean of Oral Glucose Tolerance Test class1, classII after 1st hr
and 2nd hr is within normal range i.e. 84.4 and 123.2 in diabetics it
is 140.5 and 181.7.
Conclusion: Stress hyperglycemia is associated with poor prog-
nosis than in chronic diabetes.
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